Abstract:
An anti-chafing underwear minimizes abrasive skin-to-skin contact on all skin surfaces from the mid-thigh to the waist, including the skin of the upper thigh, between the buttocks in the gluteal fold, inner thigh, scrotum, and the phallus, while retaining the genitals, the phallus, and scrotum in a relaxed position. The underwear comprises a waistband, a left panel, a right panel, a center panel, and a front panel. The lower left and right panels wrap around the thighs. Left top edge and right top edges of the left and right panels are fastened to the waistband and overlap at the rear of the waistband. Left and right upper depressed edges of the left and right panels overlap each other to separate and cover the buttocks. The front panel covers the phallus, forming a channel for natural retention of phallus. The center panel forms a channel for natural retention of scrotum.
Abstract:
An anti-chafing underwear minimizes abrasive skin-to-skin contact on all skin surfaces from the mid-thigh to the waist, including the skin of the upper thigh, between the buttocks in the gluteal fold, inner thigh, scrotum, and the phallus, while retaining the genitals, the phallus, and scrotum in a relaxed position. The underwear includes a waistband, a left panel, a right panel, a center panel, and a front panel. The lower left and right panels wrap around the thighs. Left top edge and right top edges of the left and right panels are fastened to the waistband and overlap at the rear of the waistband. Left and right upper depressed edges of the left and right panels overlap each other to separate and cover the buttocks. The front panel covers the phallus, forming a channel for natural retention of phallus. The center panel forms a channel for natural retention of scrotum.
Abstract:
Biomarkers for pre-Diabetes, Diabetes and/or a Diabetes related conditions, and methods of their use, including the biomarkers in Tables 1 and 2 such as peroxiredoxin-2, complement C1q subcomponent subunit B, sulfhydryl oxidase 1 and apolipoprotein A-IV.
Abstract:
Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.
Abstract:
A therapy or monitoring system may implement one or more techniques to mitigate interference between operation of a charging device that charges a first implantable medical device (IMD) implanted in a patient and a second IMD implanted in the patient. In some examples, the techniques may include modifying an operating parameter of the charging device in response to receiving an indication that a second IMD is implanted in the patient. The techniques also may include modifying an operating parameter of the second IMD in response to detecting the presence or operation of the charging device.
Abstract:
An optical sensor for a medical device includes a fixed lens spacing between emit and receive modules to achieve target sensor sensitivity, while varying other sensor parameters in order to increase signal amplitude without increasing power demand. The size of at least one of emit and receive module lenses of an optical sensor, and the offset between the opto-electronic component and the respective lens of at least one of emit and receive modules is decreased to increase amplitude of the signal received by the receive module from the emit module.
Abstract:
An optical sensor for a medical device includes a fixed lens spacing between emit and receive modules to achieve target sensor sensitivity, while varying other sensor parameters in order to increase signal amplitude without increasing power demand. The size of at least one of emit and receive module lenses of an optical sensor, and the offset between the opto-electronic component and the respective lens of at least one of emit and receive modules is decreased to increase amplitude of the signal received by the receive module from the emit module.
Abstract:
The present invention provides system and methods for facilitating the acquisition of content. In some embodiment, the systems and method enable a user to acquire and store content on a portable device.
Abstract:
The present invention provides a system and method for achieving a calibration-free primary atomic clock standard operating at the 0-0 transition free-atom frequency, thus creating a primary frequency standard, with attributes that include scalable to chip-scale dimensions and power consumption.
Abstract:
Electrical crosstalk between two implantable medical devices or two different therapy modules of a common implantable medical device may be evaluated, and, in some examples, mitigated. In some examples, one of the implantable medical devices or therapy modules delivers electrical stimulation to a nonmyocardial tissue site or a nonvascular cardiac tissue site, and the other implantable medical device or therapy module delivers cardiac rhythm management therapy to a heart of the patient.